Caliber Imaging & Diagnostics, Inc.
Letter data
- Company
- Caliber Imaging & Diagnostics, Inc.
- Recipient
- L. Michael Hone | Chief Executive Officer | Caliber Imaging & Diagnostics, Inc. | 50 Methodist Hill Drive | Suite 1000 | Rochester | , | NY | 14623 | United States
- Issue date
- 2018-11-06
- Posted date
- Not available
- FDA office
- Center for Devices and Radiological Health
- Subject
- Not available
- Product
- Medical Devices
- CMS ID
- 431658
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Caliber Imaging & Diagnostics, Inc.
MARCS-CMS 431658 —
November 06, 2018
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Product:
Medical Devices
Recipient:
Recipient Name
L. Michael Hone
Recipient Title
Chief Executive Officer
Caliber Imaging & Diagnostics, Inc.
50 Methodist Hill Drive
Suite 1000
Rochester
,
NY
14623
United States
Issuing Office:
Center for Devices and Radiological Health
10903 New Hampshire Avenue
Silver Spring
,
MD
20993
United States
Dear Mr. Hone:
The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter (CMS# 431658) dated January 8, 2015. Based on our evaluation, it appears that your firm has addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely yours,
/S/
For Anne M. Ferriter
Director, Division of Analysis and Program
Operations
Office of Compliance
Center for Devices and Radiological Health
cc:
Kristin Davenport
Covington & Burling LLP
One CityCenter, 850 Tenth Street, NW
Washington, DC 20001
Content current as of:
11/16/2018
Regulated Product(s)
Medical Devices